Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

The injectable prescription medicine is primarily used to treat type 2 diabetes ... exercise, improved diet and optimal sleep, Siegel said. "Having said that, these weight-loss drugs (including ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Older women who stayed on a reduced-calorie Mediterranean diet, walked and did resistance training for three years improved ...

New Delhi: Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or obesity who do not have diabetes ...

Obesity and diabetes often overshadow ... One of the largest steps is weight control. Even five to ten percent weight loss can decrease liver fat considerably. Daily exercise, even a 30-minute ...